Cyxone AB (OSTO:CYXO) Accounts Payable & Accrued Expense : kr1.15 Mil (As of Jun. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Cyxone AB Accounts Payable & Accrued Expense?

Cyxone AB's quarterly accounts payable & accrued expense increased from Dec. 2023 (kr2.10 Mil) to Mar. 2024 (kr2.34 Mil) but then declined from Mar. 2024 (kr2.34 Mil) to Jun. 2024 (kr1.15 Mil).

Cyxone AB's annual accounts payable & accrued expense declined from Dec. 2021 (kr3.59 Mil) to Dec. 2022 (kr1.93 Mil) but then increased from Dec. 2022 (kr1.93 Mil) to Dec. 2023 (kr2.10 Mil).

Cyxone AB Accounts Payable & Accrued Expense Historical Data

The historical data trend for Cyxone AB's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cyxone AB Accounts Payable & Accrued Expense Chart

Cyxone AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

1.99

2.87

3.59

1.93

2.10

Cyxone AB Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															1.93	2.14	2.10	2.34	1.15

Cyxone AB Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Cyxone AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cyxone AB (OSTO:CYXO) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Hyllie Boulevard 34, Malmo, SWE, 215 32

Website

https://www.cyxone.com

Cyxone AB is a clinical biotech company with a portfolio of immunomodulating drugs for the treatment of autoimmune diseases such as multiple sclerosis (MS) and rheumatoid arthritis (RA). The product candidates of the company include T20K and Rabeximod.

Cyxone AB Headlines

No Headlines